“cell-therapy” Archives

in
Entry Author Date Location
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bankrupt Biotech KineMed Owes More Than $1M To Gates, Others 05/13/16 San Francisco
PureTech’s Alivio Debuts With Drug-Delivery Gel for Inflammation 05/10/16 Boston
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
BioCardia Files for $50M IPO for Cell-Based Cardiovascular Therapies 07/06/15 San Francisco
SQZ Biotech Shifts to Therapy Development with $5M Series A 06/24/15 Boston
What’s Hot in Boston Biotech? Here’s the Agenda 03/26/15 Boston
Larry Corey, Cofounder of 2014 Top Biotech Juno: “It’s No Outlier” 01/05/15 Seattle
Seattle’s Fred Hutch Taps a Harvard, Merck Vet As New President 11/20/14 Seattle
From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step 11/13/14 Wisconsin
Try Then Buy? Sutro Deal Could Be Celgene’s Biggest Antibody Bet Yet 10/23/14 New York
In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products 04/25/14 Detroit Ann Arbor
Proteon, Looking Past Ill-Fated Novartis Deal, Goes it Alone 03/18/14 Boston
NeoStem Acquires Amorcyte 07/15/11 New York
Pervasis in “Advanced” Talks with Potential Partners for Blood-Vessel Healing Product, CEO Says 02/01/11 Boston
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy 10/22/10 Detroit Ann Arbor
Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy 10/18/10 Detroit Ann Arbor
Aastrom Biosciences Seeks to Catch Cell Therapy Wave, Ride Dendreon’s Coattails 06/02/10 Detroit Ann Arbor
Page 1 of 1